SCHACHLE JOSEPH K 4

What Happened

• Joseph K. Schachle, Chief Operating Officer of Opus Genetics (IRD), had 3,719 shares sold on 2026-03-16 at $5.25 per share, generating proceeds of $19,525. The sale was reported as a disposition (S) and was executed to satisfy tax withholding obligations tied to a restricted stock unit (RSU) vesting event — not a discretionary trade by the insider.

Key Details

• Transaction date and price: 2026-03-16; sale at $5.25/share.
• Total proceeds: $19,525.
• Transaction type: Reported as an open-market or private sale (S); sale was automatic for tax withholding.
• Shares owned after the transaction: Not disclosed in the Form 4 filing.
• Footnote: F1 states the shares were sold automatically by the company to cover tax withholding from an RSU vesting and the transaction was not a discretionary trade.
• Filing timeliness: Form 4 was filed 2026-03-18 — within the typical two-business-day reporting window (timely).

Context

• This was a tax-withholding sale related to RSU settlement (common practice). Such automatic sales are routine and generally reflect withholding mechanics rather than the insider’s active decision about the company’s shares. For investors, purchases by insiders can be more meaningful as a bullish signal; routine withholding sales typically carry limited informational value.